Zurich Ins Group ADR (OP:ZURVY)

34.49 +0.03 (+0.09%)

Delayed Quote Updated: 3:59 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Zurich Ins Group ADR

Underwriting the Future: A Deep Dive into AIG’s CEO Transition and Strategic Pivot

January 07, 2026

As of January 7, 2026, the global insurance landscape is witnessing a pivotal moment for one of its most storied institutions. American International Group (NYSE: AIG) has long been a barometer for the...

Via PredictStreet

Under the Radar: Hidden Value Across the Atlantic – 3 Stocks to Watch ↗

July 22, 2025

Via Benzinga

Zurich Insurance Announces $600M Acquisition Of AIG's Global Personal Travel Insurance Business To Bolster US Presence ↗

June 26, 2024

In a strategic move to bolster its travel insurance arm, Zurich Insurance has announced a $600 million deal to acquire the global personal travel insurance and assistance business of American...

Via Benzinga

Deadly Floods In California Put 38 Million Under Emergency Alert While State Faces Massive Insurance Crisis ↗

February 06, 2024

Unprecedented levels of rainfall have caused the low-elevation sections of the Los Angeles area to flood with water and mud.

Via Benzinga

Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December ↗

January 17, 2023

On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate...

Via Benzinga

OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes ↗

December 13, 2022

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022.

Via Benzinga

A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know ↗

September 12, 2022

While July gave markets around the world a breather, August reestablished 2022’s choppy financial conditions.

Via Benzinga

OTC Markets' Most Active Securities Sees A Shake-up In July ↗

August 16, 2022

July gave world markets a breather from 2022’s poor financial conditions.

Via Benzinga

These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗

August 05, 2022

The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share...

Via Benzinga

Cannabis, Veterans, PTSD And Corporate America: A US Army Vet's First-Person Experience ↗

May 03, 2022

By José Belén Cannabis, veterans, PTSD and corporate America: Quite the mix, eh?

Via Benzinga

Volume Springs Back Into The OTC Markets In March – Take A Look At Some Of The Top Movers ↗

April 14, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Trading volume appears to be moving back to OTC Markets...

Via Benzinga

The OTCQX's Top 10 Experience A Shuffle In February ↗

March 15, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Global Diversification: Switzerland And The Philippines ↗

February 05, 2022

One way to avoid or defend against slowing growth in the US is to own positions in other countries. There is likely a fund for almost any developed country you can think of that owns a basket of stocks...

Via Talk Markets

These OTC Securities Had the Most Trading Activity in July ↗

August 06, 2021

Photo by Federico Beccari on Unsplash In July, O...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.